Status:
RECRUITING
Continuous Monitoring of Vital Signs at Home (WARD HOME II)
Lead Sponsor:
Bispebjerg Hospital
Collaborating Sponsors:
Rigshospitalet, Denmark
Technical University of Denmark
Conditions:
Vital Sign Monitoring
Clinical Deterioration
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hos...
Detailed Description
Acute hospital admissions challenge the capacity of the healthcare system. Readmission is common among patients with chronic medical diseases, and many patients admitted for acute conditions are often...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical disease and scheduled for discharge to their own homes
- Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic personnel, not deemed sick enough for immediate hospital admission.
Exclusion
- Patients placed on palliative treatment.
- Acceptable chronically abnormal vital parameters of SpO2\<88%, MAP\<70, RR\>24, or HR\>110.
- Allergy to plaster, plastic, or silicone.
- A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
- If the patient was deemed not able to open the front door when visited by the investigator.
- Inability to give informed consent.
Key Trial Info
Start Date :
October 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06077851
Start Date
October 3 2023
End Date
November 1 2025
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg Hospital
Copenhagen, NV, Denmark, 2400